XML 50 R39.htm IDEA: XBRL DOCUMENT v3.20.2
Fair Value of Financial Instruments (Tables)
9 Months Ended
Sep. 30, 2020
Fair Value Disclosures [Abstract]  
Summary of Financial Liabilities Measured at Fair Value on Recurring Basis

As of September 30, 2020 and December 31, 2019, the following financial liabilities are measured at fair value on a recurring basis using significant unobservable inputs (Level 3).

 

 

 

September 30,

 

 

December 31,

 

 

 

2020

 

 

2019

 

Business acquisitions contingent consideration, current

 

$

49,170

 

 

$

8,614

 

Business acquisitions contingent consideration, long-term

 

 

9,742

 

 

 

379

 

Contingent put option

 

 

 

 

 

7,100

 

Warrant option

 

 

 

 

 

16,878

 

Conversion option

 

 

18,059

 

 

 

 

Total

 

$

76,971

 

 

$

32,971

 

 

 

Summary of Financial Instruments Measured at Fair Value on Recurring Basis

The following table sets forth the Company’s financial instruments that were measured at fair value on a recurring basis for the nine months ended September 30, 2020 and September 30, 2019:

 

 

Level 3

 

 

Embedded

Option

 

 

Business Acquisitions Contingent Consideration, Current(1)

 

 

Business Acquisitions Contingent Consideration,

Long-term(2)

 

 

Contingent

Put Option

 

 

Warrant

Options

 

 

Total

 

Balance—at December 31, 2018

$

 

 

$

2,754

 

 

$

 

 

$

 

 

$

12,818

 

 

$

15,572

 

     Acquisitions

 

 

 

 

 

31

 

 

 

 

 

 

 

 

 

 

 

 

31

 

     Changes in fair value included in earnings

 

 

 

 

(670

)

 

 

 

 

 

 

 

 

4,059

 

 

 

3,389

 

     Payment of contingent consideration

        payable

 

 

 

 

(554

)

 

 

 

 

 

 

 

 

 

 

 

(554

)

Balance—at September 30, 2019

$

 

 

$

1,561

 

 

$

 

 

$

 

 

$

16,877

 

 

$

18,438

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance—at December 31, 2019

$

 

 

$

8,614

 

 

$

379

 

 

$

7,100

 

 

$

16,878

 

 

$

32,971

 

    Foreign currency translation of contingent

       consideration payment

 

 

 

 

(208

)

 

 

 

 

 

 

 

 

 

 

 

(208

)

    Payment of contingent consideration

       payable

 

 

 

 

(12,464

)

 

 

 

 

 

 

 

 

 

 

 

(12,464

)

   Acquisitions

 

 

 

 

 

34,661

 

 

 

10,543

 

 

 

 

 

 

 

 

 

 

 

45,204

 

   Series A-2 compound embedded option

 

(9,361

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(9,361

)

   Issuance of warrant option

 

 

 

 

 

 

 

 

 

 

 

 

 

30,097

 

 

 

30,097

 

   Reclass of long term to short term contingent

      liabilities

 

 

 

 

180

 

 

 

(180

)

 

 

 

 

 

 

 

 

 

   Changes in fair value included in earnings

 

27,420

 

 

 

18,387

 

 

 

(1,000

)

 

 

(19,240

)

 

 

9,312

 

 

 

34,879

 

   Write off of the contingent put option

 

 

 

 

 

 

 

 

 

 

12,140

 

 

 

 

 

 

12,140

 

   Exercise of warrant options

 

 

 

 

 

 

 

 

 

 

 

 

 

(56,287

)

 

 

(56,287

)

Balance—at September 30, 2020

$

18,059

 

 

$

49,170

 

 

$

9,742

 

 

$

 

 

$

 

 

$

76,971

 

 

(1)

Current portion of the contingent consideration is recorded in business acquisitions contingent consideration, current.

(2)

Long term portion of the contingent consideration is recorded in business acquisitions contingent consideration, long-term.

Summary of Fair Value of Warrant Options Associated with Issuance of Redeemable Preferred Stock The fair value of the warrant options associated with the issuance of the Redeemable Series A-1 Preferred Stock and the Convertible and Redeemable Series A-2 Preferred Stock was calculated based on the Black-Sholes pricing model using the following assumptions:

 

 

July 30,

 

 

September 30,

 

Series A-1 Preferred Stock Warrant Option

2020

 

 

2019

 

Common stock value (per share)

$

22.22

 

 

$

31.60

 

Expected volatility

 

44.35

%

 

 

47.63

%

Risk-free interest rate

 

0.55

%

 

 

1.68

%

Expected life (years)

 

10

 

 

 

10

 

 

 

 

 

 

 

 

 

 

July 30,

 

 

September 30,

 

Series A-2 Preferred Stock Warrant Option

2020

 

 

2019

 

Common stock value (per share)

$

22.22

 

 

n/a

 

Expected volatility

 

44.35

%

 

n/a

 

Risk-free interest rate

 

0.55

%

 

n/a

 

Expected life (years)

 

10

 

 

n/a